A global biopharmaceutical company headquartered in London announced the layoffs of 150 Massachusetts employees last week.

GlaxoSmithKline: Attention Is Now Shifting To Vaccine Manufacturing Aug. 21, 2020 9:39 AM ET GSK plc (GSK) Stock AZN , DVAX , IBIO , MRNA , PFE , SNY , VIR , GSK 27 Comments 19 Likes Chetan Woodun ...

The Cambridge site of an international biotechnology company will cease manufacturing, leaving 150 people without a job.

British biopharmaceutical company GlaxoSmithKline will lay off 150 employees in its Cambridge operations by the end of March 2026, the company said in a notice to the state. The company said Monday ...

Earlier this year, GSK said it would invest £200 million (around $260 million) in upgrades to its manufacturing network in the UK, including a revamp of a plant in Melrose, Scotland, used to make ...

We recently published a list of Domestic Manufacturing Boom: 12 Best Pharma Stocks to Invest in Now. In this article, we are going to take a look at where GSK plc (NYSE:GSK) stands against other ...

The funding, which brings GSK’s expenditure in US manufacturing capabilities close to $1.3bn, will establish a new vaccines drug substance facility and an R&D pilot plant.

Two consequences of GlaxoSmithKline's recent decision to divest some of its less robust consumer products are the sale of a manufacturing plant in Memphis and another in Aiken, SC. The Memphis ...

GSK says EU pharma legislation overhaul could trigger investment shift ... goal of improving access to medicines for all Europeans and that the region was critical to GSK's R&D and manufacturing.

Britain's GSK will shift production of the world's first effective malaria vaccine to Indian COVID-19 vaccine developer Bharat Biotech, as part of global efforts to battle the deadly fever, the ...

GlaxoSmithKline, an early adopter of continuous processing as a way to cut drug manufacturing costs and manufacturing waste, and thus its impact on the environment, is committing $25 million to ...

MARIETTA, Pa. (WHTM) — A global biopharma company just announced that it will be investing up to $800 million to expand its long-time Lancaster County manufacturing facility. During a press ...